Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bulk water protons coordinated to gadolinium(III) on the surface of gadolinium-doped graphene quantum dots (Gd-GQDs) represent the physical substrate for signal enhancement in magnetic resonance imaging (MRI). Gadolinium is a paramagnetic lanthanide ion with seven unpaired electrons, which creates a local magnetic field that interacts with the magnetic moments of nearby water protons (Wang et al., 2014, ACS Appl. Mater. Interfaces). When water molecules from the bulk solvent coordinate with Gd³⁺ ions on the GQD surface and subsequently exchange back into the bulk, they transfer the paramagnetic relaxation effect, significantly shortening the longitudinal relaxation time (T1) of the surrounding water (Caravan, 2006, Chem. Soc. Rev.). This process results in increased signal intensity in T1-weighted MRI scans, improving the contrast and sensitivity of the imaging for diagnostic purposes. Gd-GQDs are being researched as next-generation contrast agents due to their high surface area, which allows for high Gd³⁺ loading and superior relaxivity compared to traditional chelated gadolinium agents (Yao et al., 2017, Nanoscale). While this interaction is not a therapeutic target in the traditional sense, it is the fundamental mechanism by which these diagnostic agents function to visualize diseases such as cancer and neurodegenerative disorders. Safety considerations for such systems include the potential for gadolinium ion leakage and the long-term biocompatibility of the graphene quantum dot carrier (Idée et al., 2006, Fundamental & Clinical Pharmacology).
Paramagnetic relaxation enhancement (PRE) via shortening of the longitudinal relaxation time (T1) of water protons through dipole-dipole interactions with Gd³⁺ ions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bulk water protons coordinated to gadolinium(III) on gadolinium-doped graphene quantum dot surface (Gd-GQD-coordinated water protons).